{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:12:49Z","timestamp":1790284369831,"version":"4.1.0"},"reference-count":123,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Sarcopenia and psoriasis are different inflammatory diseases that share common comorbidities (e.g., cardiovascular diseases, metabolic syndrome, obesity, autoimmune diseases, depression). Psoriasis is a dermatosis involving the skin, joints, and nails. Its estimated prevalence is 2\u20134%, and the possibility of progression to psoriatic arthritis reaches 6\u201342%. Sarcopenia is defined as reduced muscle strength, muscle quantity, and physical performance due to non-ageing related causes. It affects up to 10% of the general population. We conducted a review of the literature to provide up-to-date information about the risk of sarcopenia in psoriasis and to identify risk factors that increase this risk. The search of the literature allowed us to include 51 publications, but only five cross-sectional studies provided quantitative results on the rates of sarcopenia in psoriasis. The prevalence of sarcopenia in psoriasis varied from 9.1% to 61.7%. This wide range was caused by different definitions of sarcopenia and different cut-off values across studies. Prognostic factors include lean mass and fat mass. Further research based on the European Working Group on Sarcopenia in Older People guidelines is required. Such studies should include not only muscle mass and strength but also other factors that may influence the occurrence of sarcopenia and inflammatory markers.<\/jats:p>","DOI":"10.3390\/life12030435","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:09:58Z","timestamp":1647468598000},"page":"435","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? A Systematic Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1593-1495","authenticated-orcid":false,"given":"Zuzanna","family":"Pi\u0119towska","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Nowicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6342","authenticated-orcid":false,"given":"Jacek","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"990S","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: Origins and Clinical Relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jbspin.2018.08.001","article-title":"Sarcopenia","volume":"86","author":"Tournadre","year":"2019","journal-title":"Joint Bone Spine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European Consensus on Definition and Diagnosis","volume":"39","author":"Baeyens","year":"2010","journal-title":"Age Ageing"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/epirev\/mxs006","article-title":"Adiposity, Muscle Mass, and Muscle Strength in Relation to Functional Decline in Older Persons","volume":"35","author":"Schaap","year":"2013","journal-title":"Epidemiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(14)62000-6","article-title":"Prognostic Value of Grip Strength: Findings from the Prospective Urban Rural Epidemiology (PURE) Study","volume":"386","author":"Leong","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European Consensus on Definition and Diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jamda.2012.10.009","article-title":"Validity and Reliability of Tools to Measure Muscle Mass, Strength, and Physical Performance in Community-Dwelling Older People: A Systematic Review","volume":"14","author":"Mijnarends","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40520-015-0517-y","article-title":"Recommendations for the Conduct of Clinical Trials for Drugs to Treat or Prevent Sarcopenia","volume":"28","author":"Reginster","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: A Symptom Score to Predict Persons with Sarcopenia at Risk for Poor Functional Outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s12603-018-1067-8","article-title":"Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures","volume":"22","author":"Bahat","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s41999-017-0003-5","article-title":"Cross-Cultural Adaptation and Validation of the SARC-F to Assess Sarcopenia: Methodological Report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group","volume":"9","author":"Bahat","year":"2018","journal-title":"Eur. Geriatr. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/CIA.S245074","article-title":"Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia","volume":"15","author":"Zasadzka","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mus.23350","article-title":"Grip and Knee Extension Muscle Strength Reflect a Common Construct among Adults","volume":"46","author":"Bohannon","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Beaudart, C., McCloskey, E., Bruy\u00e8re, O., Cesari, M., Rolland, Y., Rizzoli, R., Araujo de Carvalho, I., Amuthavalli Thiyagarajan, J., Bautmans, I., and Berti\u00e8re, M.-C. (2016). Sarcopenia in Daily Practice: Assessment and Management. BMC Geriatr., 16.","DOI":"10.1186\/s12877-016-0349-4"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcsm.12268","article-title":"Pitfalls in the Measurement of Muscle Mass: A Need for a Reference Standard","volume":"9","author":"Buckinx","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_16","unstructured":"(2022, February 02). Short Physical Performance Battery (SPPB), Available online: http:\/\/www.nia.nih.gov\/research\/labs\/leps\/short-physical-performance-battery-sppb."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","article-title":"The Timed \u201cUp & Go\u201d: A Test of Basic Functional Mobility for Frail Elderly Persons","volume":"39","author":"Podsiadlo","year":"1991","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1532-5415.2008.02126.x","article-title":"Added Value of Physical Performance Measures in Predicting Adverse Health-Related Events: Results from the Health, Aging and Body Composition Study","volume":"57","author":"Cesari","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-019-00545-w","article-title":"Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A Position Paper Endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)","volume":"105","author":"Beaudart","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: An Undiagnosed Condition in Older Adults Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcsm.12147","article-title":"Welcome to the ICD-10 Code for Sarcopenia","volume":"7","author":"Anker","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jamda.2016.06.001","article-title":"Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code","volume":"17","author":"Cao","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40200-017-0302-x","article-title":"Prevalence of Sarcopenia in the World: A Systematic Review and Meta- Analysis of General Population Studies","volume":"16","author":"Shafiee","year":"2017","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ageing\/afy106","article-title":"The Prevalence of Sarcopenia in Community-Dwelling Older Adults, an Exploration of Differences between Studies and within Definitions: A Systematic Review and Meta-Analyses","volume":"48","author":"Mayhew","year":"2019","journal-title":"Age Ageing"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00223-016-0220-9","article-title":"The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action","volume":"100","author":"Ethgen","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and Its Association with Falls and Fractures in Older Adults: A Systematic Review and Meta-Analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., and Bruy\u00e8re, O. (2017). Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169548"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1164.e7","DOI":"10.1016\/j.jamda.2016.09.013","article-title":"Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis","volume":"17","author":"Chang","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ageing\/afx094","article-title":"Is Sarcopenia Associated with Depression? A Systematic Review and Meta-Analysis of Observational Studies","volume":"46","author":"Chang","year":"2017","journal-title":"Age Ageing"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-57379-3_19","article-title":"Sarcopenia and Its Impact on Quality of Life","volume":"987","author":"Tsekoura","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00223-013-9758-y","article-title":"Quality of Life in Sarcopenia and Frailty","volume":"93","author":"Rizzoli","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4093\/dmj.2015.39.1.37","article-title":"Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population: The Korean Social Life, Health and Aging Project-Health Examination Cohort","volume":"39","author":"Lee","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.archger.2019.03.020","article-title":"Association between Sarcopenia and Diabetes in Community Dwelling Elderly in the Amazon Region - Viver Mais Project","volume":"83","author":"Souza","year":"2019","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/hepr.13192","article-title":"Association between Sarcopenia and Osteoporosis in Chronic Liver Disease","volume":"48","author":"Hayashi","year":"2018","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1002\/cam4.3428","article-title":"Sarcopenia and Adverse Health-Related Outcomes: An Umbrella Review of Meta-Analyses of Observational Studies","volume":"9","author":"Xia","year":"2020","journal-title":"Cancer Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic Obesity in Older Adults: Aetiology, Epidemiology and Treatment Strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ggi.12579","article-title":"Association of Sarcopenic Obesity with the Risk of All-Cause Mortality: A Meta-Analysis of Prospective Cohort Studies","volume":"16","author":"Tian","year":"2016","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic Obesity or Obese Sarcopenia: A Cross Talk between Age-Associated Adipose Tissue and Skeletal Muscle Inflammation as a Main Mechanism of the Pathogenesis","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/1573399816666200109091449","article-title":"Understanding Sarcopenic Obesity in Terms of Definition and Health Consequences: A Clinical Review","volume":"16","author":"Nezameddin","year":"2020","journal-title":"Curr. Diabetes Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3346\/jkms.2015.30.3.264","article-title":"Relationship between Sarcopenic Obesity and Cardiovascular Disease Risk as Estimated by the Framingham Risk Score","volume":"30","author":"Kim","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.clnu.2012.06.010","article-title":"Sarcopenic Obesity: A Critical Appraisal of the Current Evidence","volume":"31","author":"Prado","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis Causes as Much Disability as Other Major Medical Diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A Systematic Review of Worldwide Epidemiology of Psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The Prevalence of Previously Diagnosed and Undiagnosed Psoriasis in US Adults: Results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","article-title":"Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis","volume":"58","author":"Gottlieb","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic Arthritis: State of the Art Review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin. Med."},{"key":"ref_52","first-page":"s216","article-title":"Psoriasis and Psoriatic Arthritis Overview","volume":"22","year":"2016","journal-title":"Suppl. Featur. Publ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of Care for the Management of Psoriasis and Psoriatic Arthritis","volume":"58","author":"Menter","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/jid.2015.87","article-title":"Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink","volume":"135","author":"Parisi","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2010.12","article-title":"Psoriasis and Cardiovascular Risk: Strength in Numbers","volume":"130","author":"Gelfand","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and Comorbid Diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-Analysis of Psoriasis, Cardiovascular Disease, and Associated Risk Factors","volume":"69","author":"Miller","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and Clinical Features of Psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1684\/ecn.2011.0294","article-title":"Cytokine Network in Psoriasis Revisited","volume":"22","author":"Pietrzak","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"ref_61","first-page":"e3491","article-title":"Effects of Weight Loss on Psoriasis: A Review of Clinical Trials","volume":"10","author":"Alotaibi","year":"2018","journal-title":"Cureus"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.jrn.2004.09.034","article-title":"Adipose Tissue and Its Relation to Inflammation: The Role of Adipokines","volume":"15","author":"Axelsson","year":"2005","journal-title":"J. Ren. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ced.12171","article-title":"Leptin Levels in Patients with Psoriasis: A Meta-Analysis","volume":"38","author":"Zhu","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/1346-8138.12121","article-title":"Adiponectin Levels in Patients with Psoriasis: A Meta-Analysis","volume":"40","author":"Zhu","year":"2013","journal-title":"J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-015-0039-9","article-title":"Increased Serum Resistin Levels Correlate with Psoriasis: A Meta-Analysis","volume":"14","author":"Huang","year":"2015","journal-title":"Lipids Health Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.mehy.2005.11.050","article-title":"Chronic Inflammation in Psoriasis and Obesity: Implications for Therapy","volume":"67","author":"Hamminga","year":"2006","journal-title":"Med. Hypotheses"},{"key":"ref_67","first-page":"761","article-title":"Compounds of Psoriasis with Obesity and Overweight","volume":"71","author":"Placek","year":"2017","journal-title":"Postepy Hig. Med. Doswiadczalnej Online"},{"key":"ref_68","first-page":"21","article-title":"Rola Tkanki T\u0142uszczowej w Uk\u0142adzie Dokrewnym","volume":"1","author":"Fichna","year":"2005","journal-title":"Endokrynol. Oty\u0142. Zab. Przem. Mat"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"754932","DOI":"10.3389\/fmed.2021.754932","article-title":"Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Med."},{"key":"ref_71","first-page":"322","article-title":"SARCOSPA - Sarcopenia in Spondyloarthritis Patients","volume":"39","author":"Aguiar","year":"2014","journal-title":"Acta Reumatol. Port."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Barone, M., Viggiani, M.T., Anelli, M.G., Fanizzi, R., Lorusso, O., Lopalco, G., Cantarini, L., Di Leo, A., Lapadula, G., and Iannone, F. (2018). Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. J. Clin. Med., 7.","DOI":"10.3390\/jcm7120504"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5114\/reum.2017.71627","article-title":"Changes in Body Composition and Bone Mineral Density in Postmenopausal Women with Psoriatic Arthritis","volume":"55","author":"Placek","year":"2017","journal-title":"Reumatologia"},{"key":"ref_74","first-page":"1033","article-title":"SAT0682 Prevalence of Sarcopenia in Patients with Chronic Inflammatory Rheumatic Diseases","volume":"76","author":"Tournadre","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Blake, T., Gullick, N.J., Hutchinson, C.E., and Barber, T.M. (2020). Psoriatic Disease and Body Composition: A Systematic Review and Narrative Synthesis. PLoS ONE, 15.","DOI":"10.1101\/2020.05.18.20104802"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Xu, J., Wan, C.S., Ktoris, K., Reijnierse, E.M., and Maier, A.B. (2021). Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis. Gerontology, 1\u201316.","DOI":"10.1159\/000517099"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jcsm.12073","article-title":"Sarcopenia and Mortality among a Population-based Sample of Community-dwelling Older Adults","volume":"7","author":"Brown","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41430-019-0508-8","article-title":"Sarcopenia as a Mortality Predictor in Community-Dwelling Older Adults: A Comparison of the Diagnostic Criteria of the European Working Group on Sarcopenia in Older People","volume":"74","author":"Bachettini","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"An, H.J., Tizaoui, K., Terrazzino, S., Cargnin, S., Lee, K.H., Nam, S.W., Kim, J.S., Yang, J.W., Lee, J.Y., and Smith, L. (2020). Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165678"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Izzo, A., Massimino, E., Riccardi, G., and Della Pepa, G. (2021). A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. Nutrients, 13.","DOI":"10.3390\/nu13010183"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"694217","DOI":"10.3389\/fimmu.2021.694217","article-title":"Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure","volume":"12","author":"Nardone","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_82","first-page":"136","article-title":"Sarcopenia in patients with autoimmune diseases","volume":"7.8","year":"2016","journal-title":"Rev. M\u00e9dica MD"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/liv.15108","article-title":"Sarcopenia Is Highly Prevalent in Children with Autoimmune Liver Diseases and Is Linked to Visceral Fat and Parent-Perceived General Health","volume":"42","author":"Amevor","year":"2022","journal-title":"Liver Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.arr.2010.05.005","article-title":"Patterns of Muscle Strength Loss with Age in the General Population and Patients with a Chronic Inflammatory State","volume":"9","author":"Beenakker","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","article-title":"Relationship of Interleukin-6 and Tumor Necrosis Factor-Alpha with Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC Study","volume":"57","author":"Visser","year":"2002","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2007-2223","article-title":"Interleukin-6 Markedly Decreases Skeletal Muscle Protein Turnover and Increases Nonmuscle Amino Acid Utilization in Healthy Individuals","volume":"93","author":"Steensberg","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/ar2658","article-title":"Rheumatoid Cachexia: A Complication of Rheumatoid Arthritis Moves into the 21st Century","volume":"11","author":"Roubenoff","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Meephansan, J., Subpayasarn, U., Komine, M., and Ohtsuki, M. (2017). Pathogenic Role of Cytokines and Effect of Their Inhibition in Psoriasis, IntechOpen.","DOI":"10.5772\/intechopen.68421"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in Psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum Levels of TNF-Alpha, IFN-Gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients with Active Psoriasis and Correlation with Disease Severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/jamadermatol.2021.3491","article-title":"Targeting Immune Checkpoints and Cytokines to Protect from Psoriasis Relapse","volume":"157","author":"Ghoreschi","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Bhatnagar, S., Panguluri, S.K., Gupta, S.K., Dahiya, S., Lundy, R.F., and Kumar, A. (2010). Tumor Necrosis Factor-\u03b1 Regulates Distinct Molecular Pathways and Gene Networks in Cultured Skeletal Muscle Cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013262"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/gerona\/glp097","article-title":"Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength","volume":"64A","author":"Schaap","year":"2009","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and Therapy of Psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.19039","article-title":"British Association of Dermatologists Guidelines for Biologic Therapy for Psoriasis 2020: A Rapid Update","volume":"183","author":"Smith","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ijd.12706","article-title":"Serum Levels of Adipocytokines in Psoriasis Patients Receiving Tumor Necrosis Factor-\u03b1 Inhibitors: Results of a Retrospective Analysis","volume":"54","author":"Campanati","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.phrs.2008.02.006","article-title":"Effect of Anti-Tumor Necrosis Factor-\u03b1 Therapies on Body Mass Index in Patients with Psoriasis","volume":"57","author":"Saraceno","year":"2008","journal-title":"Pharmacol. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1111\/j.1468-3083.2012.04571.x","article-title":"Body Weight Increment in Patients Treated with Infliximab for Plaque Psoriasis","volume":"27","author":"Florin","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fphar.2020.00481","article-title":"Impact of TNF-\u03b1 Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis","volume":"11","author":"Patsalos","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/nutd.2012.26","article-title":"The Association between Psoriasis and Obesity: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2012","journal-title":"Nutr. Diabetes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease Concomitance in Psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1529-8019.2011.01439.x","article-title":"Prospective Assessment of Body Weight and Body Composition Changes in Patients with Psoriasis Receiving Anti-TNF-\u03b1 Treatment","volume":"24","author":"Renzo","year":"2011","journal-title":"Dermatol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/FPC.0b013e32834e5e7b","article-title":"\u2212174G\/C IL-6 Gene Promoter Polymorphism Predicts Therapeutic Response to TNF-\u03b1 Blockers","volume":"22","author":"Bianchi","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archdermatol.2012.1753","article-title":"Effects of Anti-Tumor Necrosis Factor Therapy on Body Composition and Insulin Sensitivity in Patients with Psoriasis","volume":"148","author":"Kofoed","year":"2012","journal-title":"Arch. Dermatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-007-0784-3","article-title":"Effect of Etanercept on Insulin Secretion and Insulin Sensitivity in a Randomized Trial with Psoriatic Patients at Risk for Developing Type 2 Diabetes Mellitus","volume":"299","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/039463200702000408","article-title":"Effect of Etanercept on Insulin Sensitivity in Nine Patients with Psoriasis","volume":"20","author":"Marra","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","article-title":"Adipokines in Psoriasis: An Important Link between Skin Inflammation and Metabolic Alterations","volume":"17","author":"Wolk","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u201cPsoriatic March\u201d: A Concept of How Severe Psoriasis May Drive Cardiovascular Comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/jdv.13701","article-title":"The Triad Psoriasis\u2013Obesity\u2013Adipokine Profile","volume":"30","author":"Coimbra","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000481882","article-title":"Serum Leptin, Resistin, and Adiponectin Concentrations in Psoriasis: A Meta-Analysis of Observational Studies","volume":"233","author":"Kyriakou","year":"2017","journal-title":"Dermatol. Basel Switz."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/1744666X.2016.1201423","article-title":"Crosstalk between Skin Inflammation and Adipose Tissue-Derived Products: Pathogenic Evidence Linking Psoriasis to Increased Adiposity","volume":"12","author":"Chiricozzi","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/ijd.13699","article-title":"Adipokines, Psoriasis, Systemic Inflammation, and Endothelial Dysfunction","volume":"56","author":"Lynch","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_114","first-page":"239","article-title":"Adipokines and Psoriasis: The Obesity Link","volume":"179","author":"Kirby","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/eji.200838893","article-title":"Obesity Predisposes to Th17 Bias","volume":"39","author":"Winer","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Chehimi, M., Vidal, H., and Eljaafari, A. (2017). Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases. J. Clin. Med., 6.","DOI":"10.3390\/jcm6070068"},{"key":"ref_117","first-page":"3096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Piros, \u00c9.A., Szab\u00f3, \u00c1., Rencz, F., Brodszky, V., Wikonk\u00e1l, N., Miheller, P., Horv\u00e1th, M., and Holl\u00f3, P. (2021). Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters \u2018Levels, but Has No Effect on Body Composition Parameters. Life, 11.","DOI":"10.3390\/life11060535"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14712598.2018.1419183","article-title":"Effect of Anti IL-12\/23 on Body Composition: Results of Bioelectrical Impedance Analysis in Caucasian Psoriatic Patients","volume":"18","author":"Galluzzo","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-016-0889-6","article-title":"Bioelectrical Phase Angle and Psoriasis: A Novel Association with Psoriasis Severity, Quality of Life and Metabolic Syndrome","volume":"14","author":"Barrea","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.clnu.2012.05.008","article-title":"Bioelectrical Phase Angle and Impedance Vector Analysis--Clinical Relevance and Applicability of Impedance Parameters","volume":"31","author":"Norman","year":"2012","journal-title":"Clin. Nutr. Edinb. Scotl."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/dme.12710","article-title":"Bioimpedance Phase Angle Indicates Catabolism in Type 2 Diabetes","volume":"32","author":"Dittmar","year":"2015","journal-title":"Diabet. Med. J. Br. Diabet. Assoc."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3945\/ajcn.2010.29215","article-title":"Cutoff Percentiles of Bioelectrical Phase Angle Predict Functionality, Quality of Life, and Mortality in Patients with Cancer","volume":"92","author":"Norman","year":"2010","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/3\/435\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:44Z","timestamp":1760135864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/3\/435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":123,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["life12030435"],"URL":"https:\/\/doi.org\/10.3390\/life12030435","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}